158 related articles for article (PubMed ID: 19347831)
1. Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy.
Lin X; Finkelstein SD; Zhu B; Ujevich BJ; Silverman JF
Cancer; 2009 Feb; 117(1):57-66. PubMed ID: 19347831
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers and genetics in cancer development.
Hormi-Carver K; Souza RF
Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study.
Klump B; Hsieh CJ; Holzmann K; Borchard F; Gaco V; Greschniok A; Eckardt VF; Bettendorf U; Gregor M; Porschen R
Z Gastroenterol; 1999 Oct; 37(10):1005-11. PubMed ID: 10549095
[TBL] [Abstract][Full Text] [Related]
4. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
Shaheen NJ; Spechler SJ
Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
[No Abstract] [Full Text] [Related]
5. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
6. Early Barrett's carcinoma of the esophagus.
Hölscher AH; Vallböhmer D; Bollschweiler E
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
[No Abstract] [Full Text] [Related]
7. Familial Barrett's adenocarcinoma.
Melzer E; Shtoyerman R; Appelman Z; Kashtan H
Am J Gastroenterol; 2006 Mar; 101(3):677. PubMed ID: 16542304
[No Abstract] [Full Text] [Related]
8. Cryotherapy for the prevention and treatment of esophageal cancer: when does efficacy equal success?
Hernandez LV; Eisen GM
Gastrointest Endosc; 2010 Apr; 71(4):694-6. PubMed ID: 20363411
[No Abstract] [Full Text] [Related]
9. [Early esophageal carcinoma: diagnosis and endoscopic therapy].
Ell C
Z Gastroenterol; 2002 Dec; 40 Suppl 2():12-4. PubMed ID: 12466997
[No Abstract] [Full Text] [Related]
10. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
11. [No grounds for Barrett hysteria. Current monitoring strategies are adequately reliable].
Schilling D; Riemann JF
MMW Fortschr Med; 2002 Jul; 144(27-28):40-1. PubMed ID: 12198878
[No Abstract] [Full Text] [Related]
12. [Topic Complex VI: Barrett esophagus].
Messmann H; Ell C; Fein M; Kiesslich R; Ortner M; Porschen R; Stolte M
Z Gastroenterol; 2005 Feb; 43(2):184-90. PubMed ID: 15700212
[No Abstract] [Full Text] [Related]
13. Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?
Ortner MA
Curr Gastroenterol Rep; 2001 Oct; 3(5):371-4. PubMed ID: 11560793
[No Abstract] [Full Text] [Related]
14. Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus.
Bektas N; Donner A; Wirtz C; Heep H; Gabbert HE; Sarbia M
Am J Clin Pathol; 2000 Dec; 114(6):890-5. PubMed ID: 11338478
[TBL] [Abstract][Full Text] [Related]
15. [Value of the analysis of DNA cellular content by flow cytometry in Barrett esophagus].
Robaszkiewicz M; Hardy E; Volant A
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D35-9. PubMed ID: 8013781
[No Abstract] [Full Text] [Related]
16. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence.
Cai JC; Liu D; Liu KH; Zhang HP; Zhong S; Xia NS
World J Gastroenterol; 2008 Jul; 14(25):4070-6. PubMed ID: 18609693
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).
Cronin J; McAdam E; Danikas A; Tselepis C; Griffiths P; Baxter J; Thomas L; Manson J; Jenkins G
Am J Gastroenterol; 2011 Jan; 106(1):46-56. PubMed ID: 21157443
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease and Barrett's esophagus.
Anand O; Wani S; Sharma P
Endoscopy; 2008 Feb; 40(2):126-30. PubMed ID: 18058620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
